Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 04. 25.
 ÀÌÁ¾Àå±â °¡À» workshop
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2011.09.29. 16:07:45   Á¶È¸: 4106

ÀÌÁ¾Àå±â ½ÉÀå ÆǸ·, ÆǸ·µµ°ü°³¹ß workshopÀÌ ÁøÇàµÇ¾ú´Ù.

½Ã°£; 9¿ù16ÀÏ ¿ÀÈÄ 5½Ã~8½Ã, 9¿ù 17ÀÏ ¿ÀÀü 8½Ã~10½Ã

Àå¼Ò; ÀÎõ °­È­µµ ·¹ÀÌÅ© Ææ¼Ç

 

¹ßÇ¥³»¿ë 

 

±è¿ëÁø ;   Progression of xenograft development

±è¼öȯ ;   Nontoxic cross-linking & animal experiment.

À±ÀºÁ¤ ;   Space filler & their effect on tissue preservation,

             Tissue alpha-Gal titration with Western blot method

ÃÖ¼±¿µ ;   IgG & IgM Immunoglobulin change in wild type & KO mouse implantation

           Tissue alpha-Gal titration with ELISA method

¼º½ÃÂù ;   Recent experimental status of xenograft valved conduit decellularization..

ÀÓÈ«±¹ ;   Results of large animal xenograft implantation

           Xenoreactive antibody response in alpha-gal concordant animal model

ÀÌâÇÏ ;   Designs, experience of valved conduit manufacture

¿À»ï¼¼ ;   Designs, experience of implantable valve manufacture

±è±â¹ü ;   Percutaneous stented valve implantation in large animals

Á¶Àº¾Ö ;   Progress of tissue treatment & preservation 

È«°­¼± ;   Progress of valve designs and manufacture

±èÁ¤¾Æ ;   Practical points & difficulties in valve manufacturing process.

¹Ú¼­¿µ ;   Tissue mechanical test during xenograft precessing

 

À§¿Í °°Àº ³»¿ëÀ¸·Î workshopÀ» ¼º°ø¸® ÁøÇàÇÏ¿´´Ù.

±×¸®°í 17ÀÏ, ¿ÀÀü workshopÈÄ¿¡´Â À¯¼­±íÀº °­È­µµ ¸¶´Ï»ê¿¡ µî»êÀ» ÇÏ¿© °Ç°­°ú ¸¹Àº Áñ°Å¿òÀ» ¸¸³£ÇÏ¿´´Ù.

LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 04. 25.  Àüü±Û: 211  ¹æ¹®¼ö: 1023869
127 Á¦55Â÷ ´ëÇѽÉÀåÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2011.12.05.4102
126 Á¦ 43Â÷ ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2011.11.10.4248
125 Á¦ 14Â÷ ¼Ò¾Æ½ÉÀå¿Ü°ú ½ÉÆ÷Áö¿ò °ü¸®ÀÚ2011.11.10.4618
124 Á¦25Â÷ À¯·´ÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2011.10.11.4185
123 ÀÌÁ¾Àå±â °¡À» workshop °ü¸®ÀÚ2011.09.29.4106
122 Á¦ 47Â÷ ÀϺ»¼Ò¾Æ¼øȯ±âÇÐȸ ¹× Á¦ 7Â÷ ÇÑÁßÀÏ ¼Ò¾Æ½ÉÀåÇÐȸ °ü¸®ÀÚ2011.07.11.4164
121 Áß±¹ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2011.06.20.4146
120 2011 ASCVTS-ATCSA Joint Meeting °ü¸®ÀÚ2011.05.27.4193
119 ÇϾóºóÀÇ´ë, ´ëÇк´¿ø°£ Çй®±³·ùÇù¾à °ü¸®ÀÚ2011.05.23.4707
118 Áß±¹ Èæ·æ°­¼º ½ÉÀå¼ö¼ú °ü¸®ÀÚ2011.04.30.3959
RELOAD WRITE
[1] [2] [3] [4] [5] [6] [7] [8] 9 [10]  ¢º 22